This site is intended for healthcare professionals only
The CMA has slapped more than £100 million worth of fines on Advanz Pharma, HgCapital and Cinven after it concluded that the price of a thyroid drug was inflated by 1,110%.
The outcome of a Competition and Markets Authority’s (CMA) investigation, published today (July 29), found that Advanz charged an excessive price for its liothyronine tablets, which are used to treat thyroid hormone deficiency.
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.
C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…
Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.